News & Blog

Tag Archives: pharmaceutical companies

Moving The Field Toward More Patient-Focused Drug Development

Together with our partners in the Jumpstarting Brain Tumor Drug Development Coalition – Accelerate Brain Cancer Cure (ABC2), Musella Foundation for Brain Tumor Research and Education, and the Society for Neuro-Oncology – NBTS has been advocating for the brain tumor research field to take patients’ quality of life into great account during clinical trials. As […]

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

Congress Delivers Brain Tumor Community Holiday Gift

More funding for NIH to raise all ships, and specific funding for pediatric brain tumors, is welcome! More money will be available for brain tumor research in 2016, thanks to a year-end budget deal in the United States Congress that was reached today. The “omnibus” spending bill that sets government spending levels and priorities for […]

Share